Results for: oncology products

Deal fever hits global pharma sector

Cancer costs EU $170 bln annually

Roper will buy Managed Healthcare for $1 billion

Big pharma braces for M&ampA wave

Ziopharm takes bigger loss as research costs grow

Pfizer earnings dip on patent expirations, taxes

Ziopharm rises on preclinical cancer therapy study

Ziopharm's most advanced drug fails in study

Merck explores $15 billion-plus drug portfolio sale - sources

Shake-up in pharma world as Novartis, GSK announce mega-deals

AstraZeneca to buy U.S. cancer firm for up to $500 million

AstraZeneca to buy U.S. cancer firm for up to $500 million

Dendreon shares rise 4Q Provenge sales increase

Exclusive - Sanofi explores $7 billion-plus sale of drug portfolio: sources

Cold caps tested to prevent hair loss during chemo

AstraZeneca rejects sweetened Pfizer takeover bid

US moves to regulate e-cigarettes

GSK bets on emerging markets with $1 billion plan to raise stake in India...

Pfizer sales way off mark as company pursues AstraZeneca

Correction: Thermo Fisher-Life Technologies story

Stocks gain, pushing the S&P 500 to 5-year high

Concerns about cancer centers under health law

CEO: Risks key for Merck to succeed, help patients

Chavez back in Venezuela, stirs succession talk

Bartolo Colon suspended 50 games for positive test

Bartolo Colon suspended 50 games for positive test

Bartolo Colon suspended 50 games for positive test